HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Analysis of the structure of the components of the convulsive action of corazole following administration of sulazepam and its metabolites to mice].

Abstract
A study was made of the interrelationship between the minimal effective doses of pseudoclonic and clonico-tonic convulsions, and also tonic extension caused by the intravenous injection of corazol to mice and the effect of anticonvulsive action of sulazepam and its metabolites (diazepam, desmethyldiazepam and oxadiazepam) on this process. It was shown that all the compounds under study increased the values of the minimal effective doses by the recorded indices of the convulsive seizure, whereas the maximum of the anticonvulsive activity was reached 15 minutes after the sulazepam and oxazepam, and 5 to 30 min after diazepam administration. There proved to be a distinct correlation between the minimal effective doses values of the recorded indices of the confulsive seizure in the control animals which also persisted after the administration of the agents under study. It is supposed that sulazepam and its metabolites increased the minimal effective doses of corazol for the recorded effects, but failed to alter the general picture of the convulsive attack and did not influence the dispersion corazol dose-effect dependence.
AuthorsN Ia Golovenko, V G Zin'kovskii
JournalBiulleten' eksperimental'noi biologii i meditsiny (Biull Eksp Biol Med) Vol. 82 Issue 9 Pg. 1078-81 (Sep 1976) ISSN: 0365-9615 [Print] Russia (Federation)
Vernacular TitleAnaliz struktury komponentov sudorozhnogo deÄ­stviia korazola v usloviiakh vvedeniia mysham sulazepama i ego metabolitov.
PMID11012 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Anti-Anxiety Agents
  • Nordazepam
  • Oxazepam
  • Diazepam
  • Pentylenetetrazole
Topics
  • Animals
  • Anti-Anxiety Agents (therapeutic use)
  • Diazepam (therapeutic use)
  • Dose-Response Relationship, Drug
  • Male
  • Mice
  • Mice, Inbred CBA
  • Nordazepam (therapeutic use)
  • Oxazepam (therapeutic use)
  • Pentylenetetrazole (antagonists & inhibitors)
  • Seizures (chemically induced, drug therapy)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: